Astria Therapeutics Inc ATXS:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 05/16/24 EDT
9.43quote price arrow up+0.16 (+1.73%)
Volume
381,838
52 week range
4.26 - 16.90
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close9.43
  • 52 Week High16.90
  • 52 Week High Date03/25/24
  • 52 Week Low4.26
  • 52 Week Low Date11/17/23

Key Stats

  • Market Cap517.83M
  • Shares Out54.91M
  • 10 Day Average Volume0.55M
  • Dividend-
  • Dividend Yield-
  • Beta0.78
  • YTD % Change20.7

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close9.43
  • 52 Week High16.90
  • 52 Week High Date03/25/24
  • 52 Week Low4.26
  • 52 Week Low Date11/17/23
  • Market Cap517.83M
  • Shares Out54.91M
  • 10 Day Average Volume0.55M
  • Dividend-
  • Dividend Yield-
  • Beta0.78
  • YTD % Change20.7

RATIOS/PROFITABILITY

  • EPS (TTM)-2.32
  • P/E (TTM)-4.06
  • Fwd P/E (NTM)-5.74
  • EBITDA (TTM)-93.687M
  • ROE (TTM)-42.03%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-10,122.80%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/05/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Astria Therapeutics Inc

 

Profile

MORE
Astria Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for allergic and immunological diseases. The Company's lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema (HAE), a rare, debilitating and potentially life-threatening disease. Its second program, STAR-0310, is a monoclonal antibody OX40 antagonist in preclinical development for the treatment...
Kenneth Bate
Independent Chairman of the Board
Jill Milne Ph.D.
President, Chief Executive Officer, Co-Founder, Director
Noah Clauser
Chief Financial Officer
Address
75 State Street, Suite 1400
Boston, MA
02109
United States

Top Peers

SYMBOLLASTCHG%CHG
CMPS
Compass Pathways PLC
7.99-0.29-3.50%
CABA
Cabaletta Bio Inc
12.62-0.07-0.55%
OLMA
Olema Pharmaceuticals Inc
9.66-0.19-1.93%
CELC
Celcuity Inc
17.66+0.43+2.50%
ALT
Altimmune Inc
8.90+0.03+0.34%